CPT 96401: Subcutaneous or Intramuscular Nonhormonal Chemotherapy
Medicare pays $75 and commercial payers pay $129 on average nationally for this procedure.
CPT code 96401 describes administration of nonhormonal antineoplastic chemotherapy agents by subcutaneous or intramuscular injection; this is a chemotherapy administration service provided in outpatient clinic settings or other ambulatory care locations where injectable oncology therapy is delivered, and is used for coding clinician time and procedure when drugs are given via SC or IM routes.
For related coverage guidance, see recent payer policy updates: Epithelial Cell Cytology in Breast Cancer Risk Assessment, Antibody-Drug Conjugates, Chemotherapy Observation or Inpatient Hospitalization (for New Mexico Only).
Customize your policy alerts
Sign up for cpt 96401 policy alerts
Get alerted when payer policies referencing 96401 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Commercial averages sit well above Medicare for CPT 96401: Blue Cross Blue Shield, Aetna, Cigna, UnitedHealth Group and BUCA have mean rates clustered in the $115–$135 range, while Medicare’s mean is $74.9, creating a commercial-to-Medicare gap of roughly $40–$60. Notably, BUCA’s mean of $129.4 aligns with the higher end of commercial payers, exceeding Medicare by about $54.5.
Dispersion varies materially across payers. Calculating interquartile ranges (P75−P25) yields the tightest spread for UnitedHealth Group at $66.4 and the widest for Aetna at $79.0. Blue Cross Blue Shield shows a relatively narrow IQR of $63.5, Cigna an IQR of $78.0, and BUCA an IQR of $68.4. These differences indicate more consistent commercial payment levels for some payers versus greater variability for others.